APTIMA
Device
Gen-Probe, Inc.
Total Payments
$8.9M
Transactions
31,773
Doctors
21,148
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 12,408 | 10,003 |
| 2023 | $6.6M | 8,996 | 7,020 |
| 2022 | $319,123 | 6,226 | 5,148 |
| 2021 | $172,237 | 4,099 | 3,580 |
| 2020 | $1,583 | 14 | 12 |
| 2019 | $4,567 | 4 | 3 |
| 2018 | $3,319 | 12 | 12 |
| 2017 | $1,211 | 14 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.5M | 281 | 73.1% |
| Consulting Fee | $1.3M | 241 | 14.9% |
| Food and Beverage | $800,003 | 30,646 | 9.0% |
| Travel and Lodging | $223,512 | 586 | 2.5% |
| Honoraria | $45,542 | 18 | 0.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,200 | 1 | 0.0% |
Payments by Type
Research
$6.5M
281 transactions
General
$2.4M
31,492 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10940-SC2/FluP-CSP-02 | Gen-Probe, Inc. | $4.8M | 0 |
| Year 3: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $695,716 | 0 |
| 655-A10940-001 | Gen-Probe, Inc. | $299,086 | 0 |
| 670-P10936-001 | Gen-Probe, Inc. | $195,404 | 0 |
| A10960-SC2P-CSP-01 / A10960-SC2P-CSP-02 | Gen-Probe, Inc. | $147,509 | 0 |
| 655-A10960-001 | Gen-Probe, Inc. | $109,553 | 0 |
| The association of Mycoplasma genitalium and adverse perinatal outcomes in high-risk pregnant women | Gen-Probe, Inc. | $83,347 | 0 |
| Evaluation of the Aptima CMV Quant Assay in Plasma and Non-plasma samples | Gen-Probe, Inc. | $75,000 | 0 |
| TTIMS, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $36,309 | 0 |
| Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium | Gen-Probe, Inc. | $31,053 | 0 |
| Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $19,004 | 0 |
| TTIMS - Transfusion Transmissible Infection Monitoring System, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $7,500 | 0 |
| A10810-ATVPS-CSP | Gen-Probe, Inc. | $1,800 | 0 |
Top Doctors Receiving Payments for APTIMA — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Maryam Vali | Family | Skokie, IL | $285.08 | 2 |
| , D.O | Internal Medicine | West Hollywood, CA | $284.89 | 18 |
| , CRNP | Obstetrics & Gynecology | Boise, ID | $284.22 | 3 |
| , M.D | Obstetrics & Gynecology | Miami, FL | $276.99 | 6 |
| , NP | Family | Los Angeles, CA | $276.80 | 2 |
| , NP | Family | Hawthorne, CA | $276.79 | 2 |
| , FNP | Family | Carson, CA | $276.79 | 2 |
| Ugochi Nnadozie | Family | Gardena, CA | $276.79 | 2 |
| Rosemary Onwuka | Family | Carson, CA | $276.79 | 2 |
| Nkechi Perkins | Primary Care | Los Angeles, CA | $276.79 | 2 |
| , M.D | Obstetrics & Gynecology | San Antonio, TX | $275.45 | 4 |
| , M.D | Public Health & General Preventive Medicine | La Jolla, CA | $275.30 | 9 |
| , MD | General Practice | Ponce, PR | $274.09 | 3 |
| , M.D | Cytopathology | San Antonio, TX | $271.54 | 3 |
| , MD | Student in an Organized Health Care Education/Training Program | New York, NY | $271.31 | 3 |
| , M.D | Obstetrics & Gynecology | Ponce, PR | $270.97 | 5 |
| Zaskia Rodriguez | Obstetrics & Gynecology | Ponce, PR | $269.92 | 5 |
| , P.A.-C | Medical | Ft Lauderdale, FL | $267.05 | 16 |
| , M.D | Obstetrics & Gynecology | Phoenix, AZ | $266.11 | 3 |
| , M.D | Obstetrics & Gynecology | Coto Laurel, PR | $265.13 | 3 |
| , FNP-C | Family | Aurora, CO | $265.12 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Ponce, PR | $265.03 | 2 |
| Kathryn Reise | Student in an Organized Health Care Education/Training Program | Glendale, AZ | $264.54 | 6 |
| , ARNP | Psychiatric/Mental Health | Miami, FL | $264.28 | 15 |
| , MD | Obstetrics & Gynecology | Washington, DC | $263.60 | 2 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $7.8M
- Hologic Sales and Service, LLC $700,808
- Hologic, LLC $188,000
- Gen-Probe Sales & Service, Inc. $75,878
- HOLOGIC INC $44,950
- Cytyc Prenatal Products Corp. $8,000
Product Information
- Type Device
- Total Payments $8.9M
- Total Doctors 21,148
- Transactions 31,773
About APTIMA
APTIMA is a device associated with $8.9M in payments to 21,148 healthcare providers, recorded across 31,773 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 12,408 transactions to 10,003 doctors.
The most common payment nature for APTIMA is "Unspecified" ($6.5M, 73.1% of total).
APTIMA is associated with 13 research studies, including "A10940-SC2/FluP-CSP-02" ($4.8M).